NCT06975293View on ClinicalTrials.gov

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

188

Participants

Timeline

Start Date

May 5, 2025

Primary Completion Date

October 29, 2025

Study Completion Date

January 29, 2026

Conditions
Metastatic Non-small Cell Lung CancerMetastatic MelanomaMetastatic Endometrial CancerMetastatic Head-and-neck Squamous-cell CarcinomaSolid Tumor
Interventions
COMBINATION_PRODUCT

STC-15 in combination with toripalimab

STC-15 in combination with toripalimab in 21-day cycles

Trial Locations (3)

11042

RECRUITING

Northwell Health Cancer Institute, Lake Success

22031

RECRUITING

NEXT Oncology, Fairfax

78229

RECRUITING

The START Center, San Antonio

Sponsors

Collaborators (1)

Coherus Oncology, Inc.
All Listed Sponsors
collaborator

Coherus Oncology, Inc.

INDUSTRY

lead

STORM Therapeutics LTD

INDUSTRY

NCT06975293 - STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers | Biotech Hunter | Biotech Hunter